A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Antitumor activity of an adenovirus harboring two therapeutic genes, anti-VEGF ribozyme and human IL-24, in colon cancer
2009
Molecular Medicine Reports
increased vascular endothelial growth factor (VeGF) expression and tumor vascularization are correlated with both tumor progression and a poor clinical prognosis in colon cancer. There is increasing evidence that mda-7/il-24 has potent growth suppression activity and induces apoptosis in many different tumor cells. We constructed a recombinant replication-deficient adenovirus carrying both an anti-VEGF hairpin ribozyme and human il-24 (ad-rz/il-24) with an internal ribosome entry site and
doi:10.3892/mmr_00000158
pmid:21475887
fatcat:btt7yexoffbbrdwee5377njg2e